Dario Eklund has been appointed chief executive of Switzerland-based Santhera Pharmaceuticals to lead its transition into a company with new commercial products. The current CEO Thomas Meier will continue as a member of the board of directors and will chair a newly-created scientific committee. Santhera expects market entry for two new products from 2020 onwards. Mr Eklund joins Santhera from Vifor Pharma Ltd where he was chief commercial officer. He holds advanced degrees in economics and business administration from universities in Sweden, Denmark and the US.
Santhera announced the appointment on 4 November 2019.
